
ETI enhances sinonasal health and quality of life in CF youth. The MODUL-CF study (391 participants) assessed ETI therapy’s impact on CRS symptoms in children with cystic fibrosis. Significant improvements in SN-5 scores were seen within 1 month and sustained for 12 months. Sinus CT scores (LMKS) also improved in 43 patients. These findings highlight ETI’s benefits beyond pulmonary function, improving sinonasal symptoms and emotional well-being.
Like
Save
Share